Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi Russo

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Global & Regional Health Technology Assessment|January 11, 2023
How reliable are ICER's results published in current pharmacoeconomic literature? The controversial issue of price confidentialityPierluigi Russo
Drug Discovery Today|October 24, 2006
Developing a paradigm of drug innovation: an evaluation algorithmLuciano Caprino, Pierluigi Russo
Clinical Therapeutics|July 10, 2007
Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological studyPierluigi Russo, Chiara Brutti
Urologia|February 16, 2024
Brachytherapy: The urologist opinionFrancesco Pinto, Pierluigi Russo
Pharmacoeconomics|August 29, 2009
A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processesGianluca Baio, Pierluigi Russo
Italian Journal of Pediatrics|November 17, 2018
Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologistsLucia Boffi, Pierluigi Russo, Giuseppe Limongelli
Minerva Urology and Nephrology|October 23, 2025
Comment on: "Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer"Marco Finati, Pierluigi Russo, Benjamin Pradere
International Journal of Technology Assessment in Health Care|September 10, 2020
Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actionsAngelica Carletto, Matteo Zanuzzi, Annalisa Sammarco, et al.
Health Policy (Amsterdam, Netherlands)|July 13, 2021
Medicine price transparency and confidential managed-entry agreements in Europe: findings from the EURIPID surveyPierluigi Russo, Angelica Carletto, Gergely Németh, et al.
Current Therapeutic Research, Clinical and Experimental|April 26, 2014
Frequency of cardiovascular events in patients treated with anti hypertensive agents: A cohort study based on claims data generated by primary care practicePierluigi Russo, Alessandro Capone, Alessandra Sturani, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Global & Regional Health Technology Assessment|January 11, 2023
How reliable are ICER's results published in current pharmacoeconomic literature? The controversial issue of price confidentialityPierluigi Russo
Drug Discovery Today|October 24, 2006
Developing a paradigm of drug innovation: an evaluation algorithmLuciano Caprino, Pierluigi Russo
Clinical Therapeutics|July 10, 2007
Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological studyPierluigi Russo, Chiara Brutti
Urologia|February 16, 2024
Brachytherapy: The urologist opinionFrancesco Pinto, Pierluigi Russo
Pharmacoeconomics|August 29, 2009
A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processesGianluca Baio, Pierluigi Russo
Italian Journal of Pediatrics|November 17, 2018
Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologistsLucia Boffi, Pierluigi Russo, Giuseppe Limongelli
Minerva Urology and Nephrology|October 23, 2025
Comment on: "Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer"Marco Finati, Pierluigi Russo, Benjamin Pradere
International Journal of Technology Assessment in Health Care|September 10, 2020
Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actionsAngelica Carletto, Matteo Zanuzzi, Annalisa Sammarco, et al.
Health Policy (Amsterdam, Netherlands)|July 13, 2021
Medicine price transparency and confidential managed-entry agreements in Europe: findings from the EURIPID surveyPierluigi Russo, Angelica Carletto, Gergely Németh, et al.
Current Therapeutic Research, Clinical and Experimental|April 26, 2014
Frequency of cardiovascular events in patients treated with anti hypertensive agents: A cohort study based on claims data generated by primary care practicePierluigi Russo, Alessandro Capone, Alessandra Sturani, et al.
Pageof 14